Immune dysregulation increases the incidence of delayed-type drug hypersensitivity reactions. (2020)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.14127
PubMed Identifier: 31758810
Publication URI: http://europepmc.org/abstract/MED/31758810
Type: Journal Article/Review
Volume: 75
Parent Publication: Allergy
Issue: 4
ISSN: 0105-4538